Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8315	Companies
116065	Keywords
56036	Articles
62872	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 05/22/2024 at 13:00, 6 months 4 days ago

Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Moderna to host an investor event via webcast on June 3 at 6:15 PM CDT. Abstracts on mRNA-4157 for ASCO Annual Meeting. Details on mRNA-4157 (V940) therapy development

Webcast Moderna Investor Event MRNA-4157 Neoantigen Therapy
BRIEF

published on 05/13/2024 at 13:05, 6 months 13 days ago

Moderna Announces Participation in Key Investor Conferences

Investor Conferences Healthcare Financial Markets Moderna Webcasts
BRIEF

published on 05/13/2024 at 13:05, 6 months 13 days ago

Moderna annonce sa participation à des conférences clés pour les investisseurs

Marchés Financiers Soins De Santé Conférences Investisseurs Moderne Webdiffusions
PRESS RELEASE

published on 05/13/2024 at 13:00, 6 months 13 days ago

Moderna to Present at Upcoming Conferences in May/June 2024
Moderna, Inc. to participate in upcoming investor conferences, showcasing its leadership in mRNA medicine and innovative approach to disease treatment. Live webcasts available

Investor Conferences Moderna Inc. MRNA Medicine Webcasts Disease Treatment
BRIEF

published on 05/02/2024 at 12:35, 6 months 24 days ago

Moderna Reports Q1 2024 Financial Performance and Strategic Progress

Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
BRIEF

published on 05/02/2024 at 12:35, 6 months 24 days ago

Moderna publie ses résultats financiers et ses progrès stratégiques pour le premier trimestre 2024

Résultats Financiers Technologie ARNm Développement De Vaccins Moderne Vaccin Contre Le VRS
PRESS RELEASE

published on 05/02/2024 at 12:30, 6 months 24 days ago

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q1 revenues of $167 million, GAAP net loss of $1.2 billion, and diluted EPS of $(3.07). Company prepares for RSV vaccine and Spikevax® 2024-2025 formula launches, with expected product sales of $4 billion in 2024

Moderna Inc. Net Loss RSV Vaccine Q1 Revenues Spikevax 2024-2025 Formula
BRIEF

published on 04/25/2024 at 13:05, 7 months 1 day ago

Moderna to Present Diverse Research Studies at ESCMID Global Congress

COVID-19 Vaccine Moderna Vaccine Research Influenza Vaccine ESCMID Congress
BRIEF

published on 04/25/2024 at 13:05, 7 months 1 day ago

Moderna présentera diverses études de recherche au congrès mondial ESCMID

Recherche Sur Les Vaccins Moderne Vaccin Contre Le Covid-19 Vaccin Contre La Grippe Congrès ESCMID
PRESS RELEASE

published on 04/25/2024 at 13:00, 7 months 1 day ago

Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Moderna, Inc. to present data on COVID-19, influenza, respiratory syncytial virus, and cytomegalovirus vaccines at ESCMID Global Congress in Barcelona, Spain

COVID-19 Moderna Inc. Barcelona Vaccines ESCMID Global Congress

Accesswire

Published on 11/26/2024 at 17:00, 38 minutes ago

AG and Special Meeting of Shareholders December 12, 2024 - Postal Disruption - Delivery of Solicitation Materials
Published on 11/26/2024 at 16:35, 1 hour 3 minutes ago

ONAR Expands Into Healthcare Marketing With Acquisition and Rebranding of VMed to Of Kos
Published on 11/26/2024 at 16:30, 1 hour 8 minutes ago

PTOP Granted a Provisional Patent on Groundbreaking New Crypto-Marketing
Published on 11/26/2024 at 15:40, 1 hour 58 minutes ago

Forum Real Estate Income and Impact Fund Reports Q3 2024 Results
Published on 11/26/2024 at 15:30, 2 hours 8 minutes ago

Renewance Partners With U.S. Department of Labor to Launch Registered Apprenticeship Program for Skilled Battery Technicians

View all ACCESSWIRE

EQS Group

Published on 11/26/2024 at 16:45, 53 minutes ago

Swan Announces Appointment of Camille Tyan as Deputy CEO
Published on 11/26/2024 at 15:29, 2 hours 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/26/2024 at 15:28, 2 hours 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/26/2024 at 15:27, 2 hours 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Published on 11/26/2024 at 15:26, 2 hours 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc

Les Echos

Published on 11/26/2024 at 08:30, 9 hours 8 minutes ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 18/11/2024 tot 22/11/2024
Published on 11/26/2024 at 08:30, 9 hours 8 minutes ago

Cie du Bois Sauvage : Rachat d’actions propres – semaine du 18/11/2024 au 22/11/2024
Published on 11/26/2024 at 08:30, 9 hours 8 minutes ago

Cie du Bois Sauvage: Buy back of own shares – week from 18/11/2024 to 22/11/2024
Published on 11/26/2024 at 07:57, 9 hours 41 minutes ago

Neoen and Equinix sign their first PPA in Italy supporting decarbonization of the local grid
Published on 11/26/2024 at 07:57, 9 hours 41 minutes ago

Neoen et Equinix signent leur premier PPA en Italie en faveur de la décarbonation du réseau électrique

View all LES ECHOS COMFI WIRE